Skip to content
America's Blood Centers
  • About
    • Team
    • Board of Directors
    • Committees
    • ABC Strategic Plan
    • ADRP
    • Partners
    • Foundation
  • Advocacy
    • Value Framework
    • 2020 Advocacy Agenda
    • Comments & Letters
    • Resources
  • Events
    • Sponsors
      • Sponsorship Opportunities
    • Awards
  • News
    • January is National Blood Donor Month
    • ABC Publications
    • ABC Coronavirus Resources
  • Membership
    • Join Us
    • Member Resources
    • Membership Directory
    • Get Involved
    • Careers
  • For Donors
    • Convalescent Plasma Donation
    • Blood Donation FAQs
    • Blood Donation 101
    • Blood Donation Types and Collection Procedures
    • Journey of Blood
    • America’s Blood Supply
    • Find a Blood Center
    • Why Donate
  • Contact
FacebookTwitterYoutubeFlickr
  • Member Login
America's Blood Centers
  • About
    • Team
    • Board of Directors
    • Committees
    • ABC Strategic Plan
    • ADRP
    • Partners
    • Foundation
  • Advocacy
    • Value Framework
    • 2020 Advocacy Agenda
    • Comments & Letters
    • Resources
  • Events
    • Sponsors
      • Sponsorship Opportunities
    • Awards
  • News
    • January is National Blood Donor Month
    • ABC Publications
    • ABC Coronavirus Resources
  • Membership
    • Join Us
    • Member Resources
    • Membership Directory
    • Get Involved
    • Careers
  • For Donors
    • Convalescent Plasma Donation
    • Blood Donation FAQs
    • Blood Donation 101
    • Blood Donation Types and Collection Procedures
    • Journey of Blood
    • America’s Blood Supply
    • Find a Blood Center
    • Why Donate
  • Contact
April 10, 2020

America’s Blood Centers, AABB, and the American Red Cross Respond to Request for Public Comments on Section 209 of the Pandemic and All-Hazards Preparedness and Advancing Innovation Act

By America's Blood Centers

AABB, America’s Blood Centers (ABC) and the American Red Cross (ARC) are jointly submitting a response to the request for information (RFI) entitled, “Solicitation for Public Comments on Section 209 of the Pandemic and All-Hazards and Advancing Innovation Act”, which was published in the Federal Register on March 23, 2020.

Our organizations are pleased that the U.S. Department of Health and Human Services (HHS) is soliciting feedback on recommendations related to maintaining an adequate national blood supply. However, given the
significant disruption facing the United States due to the coronavirus disease (COVID-19) pandemic, we request that HHS extend the comment period to at least 90-days from publication to permit adequate time for the public to respond to the questions posed in the request and provide recommendations.

Many stakeholders, including our organizations and others in the blood community, who would weigh in on this RFI, are currently experiencing challenges related to ensuring the adequacy of the blood supply due to the
ongoing public health emergency. Additionally, the COVID-19 pandemic has highlighted the importance of the continuous recruitment of blood donors as well as other measures to promote safety and availability. We believe that information collected as part of our efforts to ensure the continued safety and availability of the nation’s blood supply during this crisis will be critical to HHS and the report to Congress. Additional time is needed to develop an appropriate response based on the lessons we are currently learning.

Thank you for the opportunity to offer these comments on the RFI. We look forward to continuing to work with the U.S. Department of Health and Human Services on recommendations related to maintaining a safe and adequate national blood supply.

Posted in News, Statements
Share this

Recent Posts

  • Blood Community Encourages Individuals to Donate Blood, Convalescent Plasma During National Blood Donor Month and Beyond
  • ADRP has been awarded a grant from Terumo Blood and Cell Technologies
  • Joint Letter to FDA Regarding COVID-19 Convalescent Plasma (CCP) Emergency Use Authorization (EUA) Implementation
  • Joint Letter to FDA Regarding COVID-19 Vaccine Deferrals
  • Recent News Regarding MSM Donor Deferral

Categories

  • Advocacy News
  • Letters
  • Letters and Comments
  • News
  • Press Releases
  • Statements

Subscribe for Updates

Sign up to receive updates from America’s Blood Centers.

* indicates required

America's Blood Centers
1717 K Street NW, Suite 900
Washington, DC 20006

Tel: 202-393-5725

Fax: 202-899-2621

  • About
    • Team
    • Board of Directors
    • Committees
    • ABC Strategic Plan
    • ADRP
    • Partners
    • Foundation
  • Advocacy
    • Value Framework
    • 2020 Advocacy Agenda
    • Comments & Letters
    • Resources
  • Events
    • Sponsors
      • Sponsorship Opportunities
    • Awards
  • News
    • January is National Blood Donor Month
    • ABC Publications
    • ABC Coronavirus Resources
  • Membership
    • Join Us
    • Member Resources
    • Membership Directory
    • Get Involved
    • Careers
  • For Donors
    • Convalescent Plasma Donation
    • Blood Donation FAQs
    • Blood Donation 101
    • Blood Donation Types and Collection Procedures
    • Journey of Blood
    • America’s Blood Supply
    • Find a Blood Center
    • Why Donate
  • Contact
  • Sitemap
  • Privacy Policy
  • Terms of Use
Become a Member
Member Login

Copyright © 2021 © America’s Blood Centers. All Rights Reserved.

Website by Yoko Co

Scroll To Top